Shanghai Artech Medical Technology Co., Ltd., a company known for its innovation in the medical device sector, has received marketing approval from China’s National Medical Products Administration (NMPA) for its balloon cryoablation catheter, a groundbreaking product designed for the treatment of paroxysmal atrial fibrillation. This novel device marks a significant advancement in the field of cardiac ablation therapies.
Artechmed, established in 2017, has solidified its position in the industry with the development of cutting-edge cryoballoon ablation (CBA) and pulsed electric field ablation (PFA) technology platforms. The company’s latest approval is a testament to its commitment to innovation and the improvement of patient care.- Flcube.com
